CTABF News and Press, Canntab Therapeutics Ltd From 05/31/19

Vancouver, British Columbia--(Newsfile Corp. - May 31, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, has signed a term sheet with Heritage Cannabis Holdings. Under the Term Sheet, Ca...

- Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 - Canntab Therapeutics Limited ( CSE:PILL.CN ) ( OTCQX:CTABF ) (FRA:TBF1.F) (the " Company " or " Canntab "), the leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blend...

- Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 - TORONTO , May 30, 2019 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the " Company " or " Canntab "), the leading innovator in hard pill oral dose therapeutic cannabinoid and...

Vancouver, British Columbia--(Newsfile Corp. - May 22, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, has received a cultivation licence from Health Canada to grow industrial hemp. Cann...

Canntab Receives Cultivation Licence for Industrial Hemp Canada NewsWire TORONTO, May 21, 2019 Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD) Additionally, Canntab's appli...

Canntab Therapeutics Now Trading on the OTCQX Best Market Canada NewsWire TORONTO, May 1, 2019 Canntab upgrades to the OTCQX Best Market for Better Investor Visibility TORONTO , May 1, 2019 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN ) (OTCQX: CTABF ) (FRA: TBF...

NEW YORK , May 1, 2019 /PRNewswire/ --  OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Canntab Therapeutics Ltd (CSE: PILL; OTCQX: CTABF), a Canadian cannabis oral dosage formulation company engaged i...

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1), a Canadian cannabis oral dosage formulation company, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids, has advanced...

Canntab Advances its Revenue Model with Recent Sales License Approval for FSD Pharma from Health Canada Canada NewsWire TORONTO, April 23, 2019 - Opens the Door for Canadian and International Sales and White Labeling - TORONTO , April 23, 2019 /CNW/ - Canntab Therapeu...

Toronto, Ontario--(Newsfile Corp. - April 22, 2019) - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company"), announced today that its wholly-owned subsidiary FV Pharma Inc. has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Cana...